# CEL Sci Corp: filings

CVM · NYSE · CIK 725363 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/cvm.md) · [Financials](/companies/cvm/financials.md) · [Filings](/companies/cvm/filings.md) · [Insiders](/companies/cvm/insiders.md)

## Reports and events: 306 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 537, 8-K 177, CORRESP 56, 10-Q 54, 424B5 50, 424B3 42, UPLOAD 39, EFFECT 28, 10-K 18, DEF 14A 18, S-8 15, ARS 13, DEFA14A 13, S-1 13, 10-Q/A 12, S-3 12, S-3/A 12, SC 13G/A 12, SC 13G 10, POS AM 7, PRER14A 7, 10-K/A 6, 3 6, NT 10-K 6, PRE 14A 6, S-1/A 6, FWP 5, AW 4, S-3MEF 4, D 3, RW 3, 424B2 2, 8-K/A 2, 25-NSE 1, 424B4 1, 8-A12B 1, ANNLRPT 1, AW WD 1, CERTNYS 1, CT ORDER 1, DEL AM 1, DRS 1, NT 10-K/A 1, NT 10-Q 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-17 | 13:05 ET | [8-K](/filings/0001654954-26-007691.md) | 5.07 Shareholder vote results | 0001654954-26-007691 |
| 2026-08-14 | 20:16 ET | [10-Q](/filings/0001654954-26-007657.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007657 |
| 2026-07-02 | 21:01 ET | [DEF 14A](/filings/0001654954-26-006496.md) | Proxy statement, period 2026-06-23 | 0001654954-26-006496 |
| 2026-06-16 | 21:03 ET | [8-K](/filings/0001654954-26-006015.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-26-006015 |
| 2026-05-15 | 21:00 ET | [10-Q](/filings/0001654954-26-005005.md) | Quarterly report, period 2026-03-31 | 0001654954-26-005005 |
| 2026-05-14 | 21:16 ET | [8-K](/filings/0001654954-26-004910.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-26-004910 |
| 2026-05-13 | 20:44 ET | [8-K](/filings/0001654954-26-004823.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-26-004823 |
| 2026-05-01 | 21:00 ET | [S-1/A](/filings/0001654954-26-004295.md) | Registration statement, amended | 0001654954-26-004295 |
| 2026-04-17 | 21:07 ET | [S-1](/filings/0001654954-26-003679.md) | Registration statement | 0001654954-26-003679 |
| 2026-02-17 | 22:01 ET | [10-Q](/filings/0001654954-26-001319.md) | Quarterly report, period 2025-12-31 | 0001654954-26-001319 |
| 2025-12-29 | 22:36 ET | [10-K](/filings/0001654954-25-014303.md) | Annual report, period 2025-09-30 | 0001654954-25-014303 |
| 2025-11-24 | 22:00 ET | [8-K](/filings/0001654954-25-013412.md) | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-25-013412 |
| 2025-11-05 | 21:31 ET | [8-K](/filings/0001654954-25-012607.md) | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-25-012607 |
| 2025-08-29 | 17:15 ET | [8-K](/filings/0001654954-25-010184.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-010184 |
| 2025-08-25 | 22:00 ET | [8-K](/filings/0001654954-25-009966.md) | 8.01 Other events | 0001654954-25-009966 |
| 2025-08-14 | 13:31 ET | [10-Q](/filings/0001654954-25-009568.md) | Quarterly report, period 2025-06-30 | 0001654954-25-009568 |
| 2025-07-14 | 20:25 ET | [8-K](/filings/0001654954-25-008033.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-008033 |
| 2025-05-23 | 20:16 ET | [8-K](/filings/0001654954-25-006091.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-006091 |
| 2025-05-19 | 20:15 ET | [8-K](/filings/0001654954-25-005876.md) | 5.07 Shareholder vote results | 0001654954-25-005876 |
| 2025-05-14 | 20:20 ET | [10-Q](/filings/0001654954-25-005606.md) | Quarterly report, period 2025-03-31 | 0001654954-25-005606 |
| 2025-04-09 | 16:59 ET | [DEF 14A](/filings/0001654954-25-004058.md) | Proxy statement, period 2025-03-31 | 0001654954-25-004058 |
| 2025-03-18 | 21:07 ET | [8-K](/filings/0001654954-25-002970.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-002970 |
| 2025-02-14 | 21:15 ET | [10-Q](/filings/0001654954-25-001578.md) | Quarterly report, period 2024-12-31 | 0001654954-25-001578 |
| 2025-01-13 | 21:16 ET | [10-K](/filings/0001654954-25-000288.md) | Annual report, period 2024-09-30 | 0001654954-25-000288 |
| 2024-12-31 | 21:15 ET | [8-K](/filings/0001654954-24-016019.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-016019 |
| 2024-11-15 | 21:30 ET | [8-K](/filings/0001654954-24-014554.md) | 5.02 Departure or appointment of officers or directors | 0001654954-24-014554 |
| 2024-11-13 | 13:30 ET | [8-K](/filings/0001654954-24-014204.md) | 8.01 Other events | 0001654954-24-014204 |
| 2024-09-17 | 21:45 ET | [8-K](/filings/0001654954-24-011975.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-011975 |
| 2024-08-14 | 20:27 ET | [10-Q](/filings/0001654954-24-010651.md) | Quarterly report, period 2024-06-30 | 0001654954-24-010651 |
| 2024-07-29 | 21:16 ET | [8-K](/filings/0001654954-24-009564.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-009564 |
| 2024-07-26 | 21:27 ET | [8-K](/filings/0001654954-24-009490.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-009490 |
| 2024-06-20 | 21:45 ET | [8-K](/filings/0001654954-24-007928.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-007928 |
| 2024-05-15 | 20:17 ET | [10-Q](/filings/0001654954-24-006411.md) | Quarterly report, period 2024-03-31 | 0001654954-24-006411 |
| 2024-04-23 | 21:00 ET | [8-K](/filings/0001654954-24-004928.md) | 5.02 Departure or appointment of officers or directors | 0001654954-24-004928 |
| 2024-04-19 | 20:51 ET | [8-K](/filings/0001654954-24-004820.md) | 5.07 Shareholder vote results | 0001654954-24-004820 |
| 2024-03-07 | 16:31 ET | [DEF 14A](/filings/0001654954-24-002762.md) | Proxy statement, period 2024-03-01 | 0001654954-24-002762 |
| 2024-02-14 | 21:31 ET | [10-Q](/filings/0001654954-24-001793.md) | Quarterly report, period 2023-12-31 | 0001654954-24-001793 |
| 2024-02-13 | 22:00 ET | [8-K](/filings/0001654954-24-001679.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-001679 |
| 2023-12-21 | 21:15 ET | [10-K](/filings/0001654954-23-015877.md) | Annual report, period 2023-09-30 | 0001654954-23-015877 |
| 2023-11-20 | 22:25 ET | [8-K](/filings/0001654954-23-014628.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-014628 |
| 2023-10-30 | 21:01 ET | [8-K](/filings/0001654954-23-013555.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-013555 |
| 2023-10-24 | 14:18 ET | [8-K](/filings/0001654954-23-013323.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-013323 |
| 2023-08-31 | 21:16 ET | [8-K](/filings/0001654954-23-011434.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-23-011434 |
| 2023-08-10 | 20:10 ET | [10-Q](/filings/0001654954-23-010485.md) | Quarterly report, period 2023-06-30 | 0001654954-23-010485 |
| 2023-07-20 | 20:10 ET | [8-K](/filings/0001654954-23-009473.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-009473 |
| 2023-07-18 | 20:05 ET | [8-K](/filings/0001654954-23-009334.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-009334 |
| 2023-07-14 | 16:25 ET | [8-K](/filings/0001654954-23-009179.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-009179 |
| 2023-07-12 | 13:01 ET | [8-K](/filings/0001654954-23-009042.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-009042 |
| 2023-05-23 | 21:15 ET | [8-K](/filings/0001654954-23-007119.md) | 5.07 Shareholder vote results | 0001654954-23-007119 |
| 2023-05-12 | 20:11 ET | [10-Q](/filings/0001654954-23-006371.md) | Quarterly report, period 2023-03-31 | 0001654954-23-006371 |

Page 1 of 7. [Older](/companies/cvm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. No prices; not investment advice.